Case Studies

Lead Scoring Through ML-Based Propensity Modeling

Posted by | Fuld & Company

An enterprise cloud solution provider wanted to increase sales conversions by better prioritizing leads.

Objective

To configure, test, and deploy an ML-based propensity model that would prioritize generated leads based on propensity and help drive conversions for the sales team.

Approach

Before Propensity Modeling - single sales strategy and marketing message to all prospects; After Propensity Modeling - personalized sales and marketing efforts tailored to propensity-based segments

Propensity modeling enables the sales team to personalize and target efforts

  • Understood the current scoring scheme and its limitations.
  • Collected data for all leads from CRM, web portal, 3P lead partners, and 3P company databases.
  • Trained and tested ML classification models on historical customer win/ loss data.
  • Tested and used the best-performing algorithm among logistic classification, Random Forest, ensemble classification, and neural networks.
  • Clustered leads and created targetable sales plays for the sales and marketing teams

Algorithms used include: classification models such as logistic classification, Random Forest, ensemble classification, and neural networks.

Outcome

  • Visualization of classification outcomes and analyses on a Tableau dashboard
  • Integrated classification model with client CRM to identify leads with high probability of conversion
  • Increased conversion rate by 11%

Tools

  

Tags: , ,

Related Resources

Read More

Mapping a rival’s brand ecosystem to guide market strategy

Introduction ​A global leader in hygiene services engaged Fuld to deliver competitive intelligence on a key rival and its portfolio […]

Read More

​Turning coffee into a growth driver for a global food services leader

​Introduction  ​A global leader in food services and facilities management serving nearly 100 million consumers daily across multiple sectors, faced […]

Read More

​How Smart Licensing of a Clinical-Stage Degrader Strengthened Oncology Pipeline

​Objective  ​A US-based biopharma company aimed to expand its immuno-oncology pipeline by in-licensing immuno-oncology strategies through a differentiated clinical-stage targeted […]

Subscribe to our mailing list for our latest updates:

Subscribe Now